TREATMENT OF HYPERTENSION IN PREGNANCY
Main Article Content
Keywords
hypertension, antihypertensives, pregnancy, complications
Abstract
In pregnancy, there is general agreement that severe hypertension should be treated with antihypertensive agents. There is no agreement as to whether mild-moderate elevations of blood pressure should be so treated. If antihypertensive agents are used, there are a large number of choices, and selection may be influenced by the stage of pregnancy and the severity of hypertension.
References
1. Why mothers die 1997-1999. The confidential enquiries into maternal deaths in the UK. London: RCOG Press, 2001.
2. Helewa ME, Burrows RF, Smith J, Williams K, Brain P, Rabkin SW. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ 1997; 157(6):715-725.
3. Duley L, Henderson-Smart D, Knight M, King J. Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review. British Medical Journal 2001; 322(7282):329-333.
4. INTAPP (INternational Trial of Antioxidant Prophylaxis in Pregnancy). Lise Tremblay@justine umontreal ca 2003.
5. Duley L, Farrell B, Spark P, Roberts B, Watkins K, Bricker L et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo- controlled trial. Lancet 2002; 359(9321):1877-1890.
6. Duley L, Carroli G, Belizan J, Gonzalez L, Campodonico L, Bergel E et al. Which Anticonvulsant for Women with Eclampsia -Evidence from the Collaborative Eclampsia Trial.Lancet 1995; 345(8963):1455-1463.
7. Irgens H.U., Reisaeter L., Irgens L.M., Lie R.T. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001; 323:1213-1217.
8. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183(1):S1-S22.
9. Brown MA, Hague WM, Higgins J, Lowe S, McCowan L, Oats J et al. The detection, investigation and management of hypertension in pregnancy: executive summary. Aust N Z J Obstet Gynaecol 2000; 40(2):133-138.
10. Rey E, LeLorier J, Burgess E, Lange IR, Leduc L. Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy. CMAJ 1997; 157(9):1245-1254.
11. Caetano M, Ornstein M, von Dadelszen P, Hannah ME, Logan AG, Gruslin A et al. A survey of Canadian practitioners regarding the management of the hypertensive disorders of pregnancy. Hypertens Pregn. In press.
12. Duley L, Henderson-Smart DJ. Drugs for rapid treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev
2000;(2):CD001449.
13. Cham C., von Dadelszen P, Waterman EJ, Magee LA. Is hydralazine the drug of choice for treatment of severe hypertension in pregnancy? A meta-
analysis of clinical trials. BMJ. In press.
14. Ben Ami M, Giladi Y, Shalev E. The combination of magnesium sulphate and nifedipine: a cause of neuromuscular blockade. Br J Obstet Gynaecol
1994; 101(3):262-263.
15. Snyder SW, Cardwell MS. Neuromuscular Blockade with Magnesium-Sulfate and Nifedipine.American Journal of Obstetrics and Gynecology 1989; 161(1):35-36.
16. CHIPS (Control of Hypertension In Pregnancy Study): The Pilot Trial. www.utoronto.ca/miru/chips 2003.
17. Magee LA, Duley L. Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2000;(4):CD002863.
18. von Dadelszen P, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: an updated metaregression analysis.
JOGC 2002; 24:941-945.
19. von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 2000; 355(9198):87-92.
20. Bayliss H., Churchill D., Beevers M., Beevers D.G. Anti-hypertensive drugs in pregnancy and fetal growth: Evidence for "pharmacological programming" in the first trimester? Hypertens Pregn 2002; 21:161-174.
21. Tan LK, de Swiet M. The management of postpartum hypertension. Bjog-An International Journal of Obstetrics and Gynaecology 2002;109(7):733-736.
22. Sadeghi S, Magee LA. Treatment for postpartum hypertension (Protocol for a Cochrane Review). The Cochrane Library 2003;(Issue 2).
23. Beardmore KS, Morris JM, Gallery EDM. Excretion of antihypertensive medication into human breast milk: A systematic review. Hypertension in Pregnancy 2002; 21(1):85-95.
2. Helewa ME, Burrows RF, Smith J, Williams K, Brain P, Rabkin SW. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ 1997; 157(6):715-725.
3. Duley L, Henderson-Smart D, Knight M, King J. Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review. British Medical Journal 2001; 322(7282):329-333.
4. INTAPP (INternational Trial of Antioxidant Prophylaxis in Pregnancy). Lise Tremblay@justine umontreal ca 2003.
5. Duley L, Farrell B, Spark P, Roberts B, Watkins K, Bricker L et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo- controlled trial. Lancet 2002; 359(9321):1877-1890.
6. Duley L, Carroli G, Belizan J, Gonzalez L, Campodonico L, Bergel E et al. Which Anticonvulsant for Women with Eclampsia -Evidence from the Collaborative Eclampsia Trial.Lancet 1995; 345(8963):1455-1463.
7. Irgens H.U., Reisaeter L., Irgens L.M., Lie R.T. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001; 323:1213-1217.
8. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183(1):S1-S22.
9. Brown MA, Hague WM, Higgins J, Lowe S, McCowan L, Oats J et al. The detection, investigation and management of hypertension in pregnancy: executive summary. Aust N Z J Obstet Gynaecol 2000; 40(2):133-138.
10. Rey E, LeLorier J, Burgess E, Lange IR, Leduc L. Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy. CMAJ 1997; 157(9):1245-1254.
11. Caetano M, Ornstein M, von Dadelszen P, Hannah ME, Logan AG, Gruslin A et al. A survey of Canadian practitioners regarding the management of the hypertensive disorders of pregnancy. Hypertens Pregn. In press.
12. Duley L, Henderson-Smart DJ. Drugs for rapid treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev
2000;(2):CD001449.
13. Cham C., von Dadelszen P, Waterman EJ, Magee LA. Is hydralazine the drug of choice for treatment of severe hypertension in pregnancy? A meta-
analysis of clinical trials. BMJ. In press.
14. Ben Ami M, Giladi Y, Shalev E. The combination of magnesium sulphate and nifedipine: a cause of neuromuscular blockade. Br J Obstet Gynaecol
1994; 101(3):262-263.
15. Snyder SW, Cardwell MS. Neuromuscular Blockade with Magnesium-Sulfate and Nifedipine.American Journal of Obstetrics and Gynecology 1989; 161(1):35-36.
16. CHIPS (Control of Hypertension In Pregnancy Study): The Pilot Trial. www.utoronto.ca/miru/chips 2003.
17. Magee LA, Duley L. Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2000;(4):CD002863.
18. von Dadelszen P, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: an updated metaregression analysis.
JOGC 2002; 24:941-945.
19. von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 2000; 355(9198):87-92.
20. Bayliss H., Churchill D., Beevers M., Beevers D.G. Anti-hypertensive drugs in pregnancy and fetal growth: Evidence for "pharmacological programming" in the first trimester? Hypertens Pregn 2002; 21:161-174.
21. Tan LK, de Swiet M. The management of postpartum hypertension. Bjog-An International Journal of Obstetrics and Gynaecology 2002;109(7):733-736.
22. Sadeghi S, Magee LA. Treatment for postpartum hypertension (Protocol for a Cochrane Review). The Cochrane Library 2003;(Issue 2).
23. Beardmore KS, Morris JM, Gallery EDM. Excretion of antihypertensive medication into human breast milk: A systematic review. Hypertension in Pregnancy 2002; 21(1):85-95.
Article Sidebar
Published
Dec 8, 2018
Article Details
How to Cite
Magee, L. A., & von Dadelszen, P. (2018). TREATMENT OF HYPERTENSION IN PREGNANCY. Journal of Population Therapeutics and Clinical Pharmacology, 11(2). https://mail.jptcp.com/index.php/jptcp/article/view/78
Issue
Section
Articles
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Magee, L. A., & von Dadelszen, P. (2018). TREATMENT OF HYPERTENSION IN PREGNANCY. Journal of Population Therapeutics and Clinical Pharmacology, 11(2). https://mail.jptcp.com/index.php/jptcp/article/view/78